HCA Healthcare Inc
$
139.48
-1.75 (-1.24%)
| Volume: | 1,091,141 | Avg Vol (1m): | 1,665,094 |
| Market Cap $: | 47.75 Bil | Enterprise Value $: | 84.13 Bil |
| P/E (TTM): | 13.35 | P/B: | 0.00 |
| Earnings Power Value | -27.36 |
| Net Current Asset Value | -104.55 |
| Tangible Book | -35.72 |
| Projected FCF | 88.53 |
| Median P/S Value | 100.17 |
| Graham Number | 0 |
| Peter Lynch Value | 141.57 |
| DCF (FCF Based) | 173.75 |
| DCF (Earnings Based) | 111.73 |
1Y (-%)
Manual of Stocks™ Web
Financial Strength : 3.8/10
GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
| Current | vs industry | vs history | |
|---|---|---|---|
| Cash-to-Debt | 0.02 |
Cash-To-Debt range over the past 10 years
Min: 0, Med: 0.02, Max: 0.14
Current: 0.02
| |
| Equity-to-Asset | -0.10 |
Equity-to-Asset range over the past 10 years
Min: -0.5, Med: 0.21, Max: 0.42
Current: -0.1
| |
| Debt-to-Equity | -8.00 |
Debt-to-Equity range over the past 10 years
Min: -8, Med: 0.86, Max: 4.71
Current: -8
| |
| Debt-to-EBITDA | 3.71 |
Debt-to-EBITDA range over the past 10 years
Min: 3.5, Med: 4.11, Max: 4.91
Current: 3.71
| |
| Interest Coverage | 3.92 |
Interest Coverage range over the past 10 years
Min: 1.91, Med: 2.94, Max: 3.92
Current: 3.92
| |
| Piotroski F-Score | 7 |
0
1
2
3
4
5
6
7
8
9
| |
| Altman Z-Score | 2.16 |
DISTRESS
GREY
SAFE
| |
| WACC vs ROIC % |
ROIC 19.52%
WACC 7.29%
| ||
Profitability & Growth : 8/10
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
| Current | vs industry | vs history | |
|---|---|---|---|
| Operating Margin % | 14.65 |
Operating Margin range over the past 10 years
Min: 12.65, Med: 14.6, Max: 15.07
Current: 14.65
| |
| Net Margin % | 7.71 |
Net Margin range over the past 10 years
Min: 3.51, Med: 5.08, Max: 8.3
Current: 7.71
| |
| ROA % | 9.41 |
ROA range over the past 10 years
Min: 4.35, Med: 6.29, Max: 9.99
Current: 9.41
| |
| ROC (Joel Greenblatt) % | 30.92 |
ROC (Joel Greenblatt) range over the past 10 years
Min: 28.41, Med: 30.64, Max: 37.66
Current: 30.92
| |
| 3-Year Total Revenue Growth Rate | 5.60 |
3-Year Revenue Growth Rate range over the past 10 years
Min: -7.8, Med: 8.55, Max: 24.3
Current: 12.2
| |
| 3-Year Total EBITDA Growth Rate | 7.60 |
3-Year EBITDA Growth Rate range over the past 10 years
Min: -40.4, Med: 9.6, Max: 76.1
Current: 14.3
| |
| 3-Year EPS w/o NRI Growth Rate | 28.80 |
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 12.7, Max: 88.4
Current: 28.8
|
» HCA's 30-Y Financials
Financials (Next Earnings Date: 2019-07-30)
Guru Trades Click for details
Guru Trades in
SEC Filings
Gurus Latest Trades with NYSE:HCA
» Interactive Chart
Peter Lynch Chart
Business Description
| Industry | Health Care Providers » Health Care Providers   NAICS : 622110   SIC : 8062 |
| Compare | XTER:FRE XTER:FME SZSE:300015 BKK:BDMS-F XKLS:5225 NYSE:UHS ASX:RHC NYSE:DVA ASX:SHL BSP:HAPV3 LSE:NMC NYSE:EHC NYSE:CHE BKK:BH-Q NAS:AMED NAS:LHCG NAS:ACHC LSE:MDC NSE:APOLLOHOSP NYSE:AMN |
| Traded in other countries | 2BH.Germany 0J1R.UK |
| Address | One Park Plaza, Nashville, TN, USA, 37203 |
| Accounting for about 5% of total U.S. hospital admissions, HCA is the largest private hospital owner and operator in the United States. It operates 170 hospitals and 118 outpatient centers, offering a broad range of health services. HCA has operations in 20 states and in England, but a majority of its operations are in the Southern United States, particularly in Florida and Texas. Outpatient services make up about 40% of HCA's patient revenue. | |
Ratios
| Current | vs industry | vs history | |
|---|---|---|---|
| PE Ratio (TTM) | 13.35 |
PE Ratio range over the past 10 years
Min: 4.08, Med: 13.27, Max: 19.72
Current: 13.35
| |
| Forward PE Ratio | 13.79 | N/A | |
| PE Ratio without NRI | 13.35 |
PE without NRI range over the past 10 years
Min: 4.08, Med: 13.27, Max: 19.72
Current: 13.35
| |
| Price-to-Owner-Earnings | 16.74 |
Price-to-Owner-Earnings range over the past 10 years
Min: 2.31, Med: 13.87, Max: 43.21
Current: 16.74
| |
| PS Ratio | 1.03 |
PS Ratio range over the past 10 years
Min: 0.32, Med: 0.74, Max: 1.12
Current: 1.03
| |
| Price-to-Free-Cash-Flow | 17.63 |
Price-to-Free-Cash-Flow range over the past 10 years
Min: 4.08, Med: 12.08, Max: 20.84
Current: 17.63
| |
| Price-to-Operating-Cash-Flow | 7.63 |
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 2.57, Med: 5.96, Max: 8.64
Current: 7.63
| |
| EV-to-EBIT | 11.94 |
EV-to-EBIT range over the past 10 years
Min: 6.3, Med: 10.7, Max: 12.6
Current: 11.94
| |
| EV-to-EBITDA | 8.97 |
EV-to-EBITDA range over the past 10 years
Min: 5, Med: 7.9, Max: 9.4
Current: 8.97
| |
| EV-to-Revenue | 1.76 |
EV-to-Revenue range over the past 10 years
Min: 1.2, Med: 1.5, Max: 1.9
Current: 1.76
| |
| PEG Ratio | 1.02 |
PEG Ratio range over the past 10 years
Min: 0.51, Med: 1.75, Max: 4.62
Current: 1.02
| |
| Shiller PE Ratio | 23.37 |
Shiller PE Ratio range over the past 10 years
Min: 6.16, Med: 16.5, Max: 25.8
Current: 23.37
| |
| Current Ratio | 1.05 |
Current Ratio range over the past 10 years
Min: 0.81, Med: 1.51, Max: 2.25
Current: 1.05
| |
| Quick Ratio | 0.89 |
Quick Ratio range over the past 10 years
Min: 0.71, Med: 1.34, Max: 2.12
Current: 0.89
| |
| Days Inventory | 20.83 |
Days Inventory range over the past 10 years
Min: 17.77, Med: 19.82, Max: 57.7
Current: 20.83
| |
| Days Sales Outstanding | 56.69 |
Days Sales Outstanding range over the past 10 years
Min: 44.84, Med: 53.63, Max: 56.69
Current: 56.69
| |
| Days Payable | 33.17 |
Days Payable range over the past 10 years
Min: 30.44, Med: 32.22, Max: 109.47
Current: 33.17
|
Dividend & Buy Back
| Current | vs industry | vs history | |
|---|---|---|---|
| Dividend Yield % | 1.08 |
Trailing Dividend Yield range over the past 10 years
Min: 0.34, Med: 0.79, Max: 1.26
Current: 1.08
| |
| Dividend Payout Ratio | 0.14 |
Dividend Payout Ratio range over the past 10 years
Min: 0.13, Med: 0.13, Max: 0.14
Current: 0.14
| |
| Forward Dividend Yield % | 1.15 | N/A | |
| Yield-on-Cost (5-Year) % | 1.07 |
Yield-on-Cost (5y) range over the past 10 years
Min: 0.34, Med: 0.79, Max: 1.26
Current: 1.07
| |
| 3-Year Share Buyback Rate | 4.80 |
3-Year Share Buyback Rate range over the past 10 years
Min: -202.3, Med: 1.3, Max: 12
Current: 4.8
|
Valuation & Return
| Current | vs industry | vs history | |
|---|---|---|---|
| Price-to-Projected-FCF | 1.58 |
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 1.26, Med: 2.14, Max: 17.96
Current: 1.58
| |
| Price-to-DCF (Earnings Based) | 1.25 |
Price-to-Intrinsic-Value-DCF (Earnings Based) range over the past 10 years
Min: 0.81, Med: 1.31, Max: 1.73
Current: 1.25
| |
| Price-to-Median-PS-Value | 1.39 |
Price-to-Median-PS-Value range over the past 10 years
Min: 0.48, Med: 0.99, Max: 1.46
Current: 1.39
| |
| Price-to-Peter-Lynch-Fair-Value | 0.99 |
Price-to-Peter-Lynch-Fair-Value range over the past 10 years
Min: 0.58, Med: 1.65, Max: 3.69
Current: 0.99
| |
| Earnings Yield (Joel Greenblatt) % | 8.37 |
Earnings Yield (Greenblatt) range over the past 10 years
Min: 8, Med: 9.3, Max: 16
Current: 8.37
| |
| Forward Rate of Return (Yacktman) % | 18.13 |
Forward Rate of Return range over the past 10 years
Min: 9.8, Med: 15.2, Max: 19.8
Current: 18.13
|
More Statistics
| Revenue (TTM) (Mil) $ | 47,771 |
| EPS (TTM) $ | 10.44 |
| Beta | 1.25 |
| Volatility % | 33.75 |
| 52-Week Range $ | 105.64 - 147.42 |
| Shares Outstanding (Mil) | 342.31 |
Analyst Estimate
Piotroski F-Score Details
| Piotroski F-Score | 7 |
| Positive ROA | Y |
| Positive CFROA | Y |
| Higher ROA yoy | Y |
| CFROA > ROA | Y |
| Lower Leverage yoy | Y |
| Higher Current Ratio yoy | N |
| Less Shares Outstanding yoy | Y |
| Higher Gross Margin yoy | Y |
| Higher Asset Turnover yoy | N |